A Study of Ritlecitinib for Moderate Hair Loss from Alopecia Areata
Treatments studied
Part of Skin clinical trials.
This study tests if the medicine ritlecitinib can help regrow hair in people with alopecia areata, a condition that causes patchy hair loss. It's for young people and adults who have lost between 20% and 50% of their scalp hair for at least 6 months but no more than 10 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older (adults are also welcome).
- You have been diagnosed with alopecia areata (patchy hair loss) and no other reason for your hair loss.
- You have lost more than 20% but less than 50% of your scalp hair.
- Your current hair loss episode has lasted between 6 months and 10 years.
- You do not have other conditions that cause hair loss, like scalp psoriasis, lupus, or thyroid problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different doses of a pill called ritlecitinib to see if it can help regrow hair in people with significant hair loss from alopecia areata. It is for people aged 12 and older who have lost at least half of their scalp hair.
This trial provides early access to an investigational drug called ritlecitinib for people with severe alopecia areata who have not responded to other treatments. It aims to help regrow hair by targeting the immune system.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This Phase 2 study tests ruxolitinib to see if it safely helps regrow hair in people whose alopecia areata is linked to APECED (a rare immune condition). You may qualify if you have significant scalp hair loss for at least 6 months and haven’t had regrowth with other treatments.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
This trial tests an experimental oral tablet (VC005) in teenagers with severe alopecia areata, a condition that causes patchy hair loss. The goal is to see if the drug is safe and may help regrow hair.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.